125 related articles for article (PubMed ID: 28445934)
1. Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer.
Zhu XX; Yan YW; Ai CZ; Jiang S; Xu SS; Niu M; Wang XZ; Zhong GS; Lu XF; Xue Y; Tian S; Li G; Tang S; Jiang YZ
Oncotarget; 2017 Apr; 8(15):24483-24490. PubMed ID: 28445934
[TBL] [Abstract][Full Text] [Related]
2. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
Wang X; Lyu J; Ji A; Zhang Q; Liao G
Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
[TBL] [Abstract][Full Text] [Related]
3. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
4. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
[TBL] [Abstract][Full Text] [Related]
5. Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells.
Yang YM; Chang JW
Cancer Invest; 2008 Aug; 26(7):725-33. PubMed ID: 18608209
[TBL] [Abstract][Full Text] [Related]
6. JARID2 inhibits leukemia cell proliferation by regulating CCND1 expression.
Su CL; Deng TR; Shang Z; Xiao Y
Int J Hematol; 2015 Jul; 102(1):76-85. PubMed ID: 25939703
[TBL] [Abstract][Full Text] [Related]
7. LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2.
Liu Y; Huang X; Guo L; Luo N
Urol Int; 2022; 106(3):304-312. PubMed ID: 33789312
[TBL] [Abstract][Full Text] [Related]
8. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
[TBL] [Abstract][Full Text] [Related]
9. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
[TBL] [Abstract][Full Text] [Related]
10. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
[TBL] [Abstract][Full Text] [Related]
11. miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
Guo Y; Ying L; Tian Y; Yang P; Zhu Y; Wang Z; Qiu F; Lin J
FEBS J; 2013 Sep; 280(18):4531-8. PubMed ID: 23815091
[TBL] [Abstract][Full Text] [Related]
12. MacroH2A1 downregulation enhances the stem-like properties of bladder cancer cells by transactivation of Lin28B.
Park SJ; Shim JW; Park HS; Eum DY; Park MT; Mi Yi J; Choi SH; Kim SD; Son TG; Lu W; Kim ND; Yang K; Heo K
Oncogene; 2016 Mar; 35(10):1292-301. PubMed ID: 26028027
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract][Full Text] [Related]
14. The KMT1A-GATA3-STAT3 Circuit Is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells.
Yang Z; He L; Lin K; Zhang Y; Deng A; Liang Y; Li C; Wen T
Clin Cancer Res; 2017 Nov; 23(21):6673-6685. PubMed ID: 28765327
[No Abstract] [Full Text] [Related]
15. JARID2 Functions as a Tumor Suppressor in Myeloid Neoplasms by Repressing Self-Renewal in Hematopoietic Progenitor Cells.
Celik H; Koh WK; Kramer AC; Ostrander EL; Mallaney C; Fisher DAC; Xiang J; Wilson WC; Martens A; Kothari A; Fishberger G; Tycksen E; Karpova D; Duncavage EJ; Lee Y; Oh ST; Challen GA
Cancer Cell; 2018 Nov; 34(5):741-756.e8. PubMed ID: 30423295
[TBL] [Abstract][Full Text] [Related]
16. Jarid2 Is Implicated in the Initial Xist-Induced Targeting of PRC2 to the Inactive X Chromosome.
da Rocha ST; Boeva V; Escamilla-Del-Arenal M; Ancelin K; Granier C; Matias NR; Sanulli S; Chow J; Schulz E; Picard C; Kaneko S; Helin K; Reinberg D; Stewart AF; Wutz A; Margueron R; Heard E
Mol Cell; 2014 Jan; 53(2):301-16. PubMed ID: 24462204
[TBL] [Abstract][Full Text] [Related]
17. Polycomb recruitment at the Class II transactivator gene.
Boyd NH; Morgan JE; Greer SF
Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
[TBL] [Abstract][Full Text] [Related]
18. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.
He W; Cai Q; Sun F; Zhong G; Wang P; Liu H; Luo J; Yu H; Huang J; Lin T
Biochim Biophys Acta; 2013 Oct; 1832(10):1528-37. PubMed ID: 23688781
[TBL] [Abstract][Full Text] [Related]
19. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
20. Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N
Gu C; Wang Z; Zhou N; Li G; Kou Y; Luo Y; Wang Y; Yang J; Tian F
Mol Cancer; 2019 Nov; 18(1):168. PubMed ID: 31760940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
